D. E. Shaw & Co. Inc. Sells 147,442 Shares of Nutrien Ltd (NYSE:NTR)

Share on StockTwits

D. E. Shaw & Co. Inc. lowered its holdings in shares of Nutrien Ltd (NYSE:NTR) by 8.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,523,561 shares of the company’s stock after selling 147,442 shares during the period. D. E. Shaw & Co. Inc. owned about 0.27% of Nutrien worth $81,516,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in NTR. Cambiar Investors LLC bought a new position in shares of Nutrien during the 2nd quarter valued at $166,998,000. National Pension Service bought a new position in shares of Nutrien during the 2nd quarter valued at $69,931,000. Mackenzie Financial Corp grew its holdings in shares of Nutrien by 11.3% during the 2nd quarter. Mackenzie Financial Corp now owns 8,580,722 shares of the company’s stock valued at $458,725,000 after purchasing an additional 872,389 shares during the last quarter. Mawer Investment Management Ltd. grew its holdings in shares of Nutrien by 19.8% during the 1st quarter. Mawer Investment Management Ltd. now owns 3,625,417 shares of the company’s stock valued at $191,258,000 after purchasing an additional 598,451 shares during the last quarter. Finally, Galibier Capital Management Ltd. bought a new position in shares of Nutrien during the 2nd quarter valued at $24,358,000. 65.50% of the stock is currently owned by institutional investors.

NTR traded down $0.52 during trading on Friday, hitting $51.57. 714,520 shares of the stock traded hands, compared to its average volume of 894,827. The firm has a market capitalization of $29.64 billion, a P/E ratio of 19.17, a price-to-earnings-growth ratio of 2.53 and a beta of 0.91. The firm has a 50-day moving average of $50.82 and a 200 day moving average of $51.89. Nutrien Ltd has a 12-month low of $43.96 and a 12-month high of $58.99.

Nutrien (NYSE:NTR) last announced its quarterly earnings results on Monday, July 29th. The company reported $1.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.59 by ($0.01). The business had revenue of $8.66 billion for the quarter, compared to analyst estimates of $8.17 billion. During the same period in the prior year, the firm earned $1.48 earnings per share. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities research analysts expect that Nutrien Ltd will post 2.56 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 17th. Stockholders of record on Monday, September 30th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 3.49%. This is a boost from Nutrien’s previous quarterly dividend of $0.43. The ex-dividend date is Friday, September 27th. Nutrien’s dividend payout ratio (DPR) is currently 63.94%.

Several research firms recently commented on NTR. UBS Group set a $62.00 target price on shares of Nutrien and gave the company a “buy” rating in a report on Tuesday, August 27th. Citigroup set a $61.00 price target on shares of Nutrien and gave the company a “buy” rating in a research report on Wednesday, July 31st. BMO Capital Markets set a $60.00 price target on shares of Nutrien and gave the company a “buy” rating in a research report on Wednesday, July 31st. Zacks Investment Research cut shares of Nutrien from a “hold” rating to a “sell” rating in a research report on Friday, September 6th. Finally, TD Securities increased their price target on shares of Nutrien from $68.00 to $69.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $61.54.

About Nutrien

Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.

Featured Article: Marijuana Stocks

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Federal Signal  Upgraded to Buy at Zacks Investment Research
Federal Signal Upgraded to Buy at Zacks Investment Research
GlaxoSmithKline’s  Neutral Rating Reaffirmed at JPMorgan Chase & Co.
GlaxoSmithKline’s Neutral Rating Reaffirmed at JPMorgan Chase & Co.
ChannelAdvisor  Raised to “Buy” at Zacks Investment Research
ChannelAdvisor Raised to “Buy” at Zacks Investment Research
Goldman Sachs Group Reiterates “Buy” Rating for Alliance Data Systems
Goldman Sachs Group Reiterates “Buy” Rating for Alliance Data Systems
VictoryShares US Discovery Enhanced Volatility Wtd ETF  Stock Price Up 1.1%
VictoryShares US Discovery Enhanced Volatility Wtd ETF Stock Price Up 1.1%
Packaging Corp Of America  Price Target Raised to $108.00 at Citigroup
Packaging Corp Of America Price Target Raised to $108.00 at Citigroup


© 2006-2019 Ticker Report